Lumexa Imaging (LMRI) reported Q1 adjusted earnings late Tuesday of $0.18 per diluted share, up from $0.04 a year earlier.
Revenue for the quarter ended March 31 was $252.5 million, up from $245 million a year earlier.
Analysts surveyed by FactSet expected $249.5 million.
For full-year 2026, the company still expects adjusted EPS of $0.71 to $0.77 on revenue of $1.05 billion to $1.10 billion. Analysts surveyed by FactSet expect revenue of $1.06 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.